![PDF) The Avon Longitudinal Study of Parents and Children -A resource for COVID-19 research: Antibody testing results, April -June 2021 [version 1; peer review: awaiting peer review] PDF) The Avon Longitudinal Study of Parents and Children -A resource for COVID-19 research: Antibody testing results, April -June 2021 [version 1; peer review: awaiting peer review]](https://i1.rgstatic.net/publication/355437592_The_Avon_Longitudinal_Study_of_Parents_and_Children_-A_resource_for_COVID-19_research_Antibody_testing_results_April_-June_2021_version_1_peer_review_awaiting_peer_review/links/61704037766c4a211cfe75a4/largepreview.png)
PDF) The Avon Longitudinal Study of Parents and Children -A resource for COVID-19 research: Antibody testing results, April -June 2021 [version 1; peer review: awaiting peer review]
![Development of a Compatibility Chart for Intravenous Y-Site Drug Administration in a Pediatric Intensive Care Unit | Article | NursingCenter Development of a Compatibility Chart for Intravenous Y-Site Drug Administration in a Pediatric Intensive Care Unit | Article | NursingCenter](https://www.nursingcenter.com/wkhlrp/handlers/Cv.png?key=cv_00129804-201203000-00000)
Development of a Compatibility Chart for Intravenous Y-Site Drug Administration in a Pediatric Intensive Care Unit | Article | NursingCenter
![PDF) Exploring the impact of selection bias in observational studies of COVID-19: a simulation study PDF) Exploring the impact of selection bias in observational studies of COVID-19: a simulation study](https://i1.rgstatic.net/publication/366086989_Exploring_the_impact_of_selection_bias_in_observational_studies_of_COVID-19_a_simulation_study/links/63913555484e65005bf19d43/largepreview.png)
PDF) Exploring the impact of selection bias in observational studies of COVID-19: a simulation study
![IJMS | Free Full-Text | Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma IJMS | Free Full-Text | Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma](https://www.mdpi.com/ijms/ijms-23-11248/article_deploy/html/images/ijms-23-11248-g001.png)
IJMS | Free Full-Text | Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
![PTGS2–899G>C and prostate cancer risk: a population-based nested case–control study (ProtecT) and a systematic review with meta-analysis | Prostate Cancer and Prostatic Diseases PTGS2–899G>C and prostate cancer risk: a population-based nested case–control study (ProtecT) and a systematic review with meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2009.18/MediaObjects/41391_2009_Article_BFpcan200918_Fig1_HTML.jpg)